dr. denes discusses biosimilar pricing in oncology
Published 5 years ago • 66 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
0:58
dr. denes on the use of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
0:55
dr. weise discusses the value of biosimilars in oncology
-
1:42
dr. verma discusses challenges with biosimilars in oncology
-
1:08
dr. litton discusses the potential advantage of using biosimilars in oncology
-
5:59
dr ali mcbride discusses the role of biosimilars in oncology
-
4:20
the biosimilar development process
-
4:12
the basics of biosimilars
-
5:20
data requirements for biosimilars
-
0:47
dr. o'regan discusses biosimilar education in oncology
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
5:56
the complexity of choosing biosimilars in oncology
-
1:16
dr. weise discusses the future of biosimilars in oncology
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
1:17
dr. mcbride on the emergence of biosimilars in oncology
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
6:43
biosimilars